Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status  Phase of research How it helps Latest publication
BRII-198
Potential treatment - theoretical effect Experimental Antiviral Dec/23/2021
ΔABP-α2
Potential treatment - theoretical effect Experimental Antiviral Mar/01/2021
2-Bromo-3-fluoro-N-[(1-methyl-1H-indol-3-yl)sulfonyl]benzamide
Potential treatment - theoretical effect Experimental Antiviral Feb/20/2021
11-(1,3-Benzodioxol-5-yl)-5-bromo-8,9-dihydro-[1,3]benzodioxolo[7,6-g]phthalazine-7,10-dione
Potential treatment - theoretical effect Experimental Antiviral Feb/22/2021
(4Ar,5R,6aS,6aR,6bR,8aS,11R,14aR,14bR)-5-hydroxy-11-(hydroxymethyl)-4,4,6a,6b,8a,11,14b-heptamethyl-2,4a,5,6,6a,7,8,9,10,13,14,14a-dodecahydro-1H-picen-3-one
Potential treatment - theoretical effect Experimental Antiviral Feb/22/2021
5-(3,4-Dimethoxyphenyl)-2-methyl-7-(5,6,7,8-tetrahydronaphthalen-2-yl)-5,7-dihydro-[1,3]thiazolo[3,2-a]pyrimidine-3,6-dione
Potential treatment - theoretical effect Experimental Antiviral Feb/22/2021
Imiglitazar
Potential treatment - theoretical effect Experimental Antiviral Feb/23/2021
MLN-4760
Potential treatment - theoretical effect Experimental Antiviral Mar/03/2021
S-8510
Potential treatment - theoretical effect Experimental Antiviral Feb/08/2021
(2s,3r)-2-(3,4-Dihydroxyphenyl)-3,7-dihydroxy-2,3-dihydro-4h-chromen-4-one
Potential treatment - theoretical effect Experimental Antiviral Feb/08/2021
1-{4-[(Methoxyacetyl)amino]phenyl}-N-(3-methoxypropyl)cyclohexanecarboxamide
Potential treatment - theoretical effect Experimental Antiviral
2-(Morpholin-4-yl)-2-oxoethyl 6-(4-methoxyphenyl)-3-methyl-1-phenyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylate
Potential treatment - theoretical effect Experimental Antiviral Dec/17/2020
N-(3-(Furan-2-yl)-1-(4-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)-1H-pyrazol-5-yl)-3-methylbenzamide
Potential treatment - theoretical effect Experimental Antiviral Dec/17/2020
N-[(2R)-2-(1H-Indol-3-yl)-2-thiophen-2-ylethyl]-2-oxo-1H-quinoline-4-carboxamide
Potential treatment - theoretical effect Experimental Antiviral Dec/17/2020
Galidesivir
Potential treatment - theoretical effect Experimental Antiviral Mar/25/2021
scFv-IL6R-Fc
Potential treatment - theoretical effect Experimental Other treatment Jun/11/2021
Naproxol
Potential treatment - theoretical effect Experimental Other treatment Apr/12/2021
8-{3-hydroxy-4-[(7-hydroxynaphthalen-2-yl)oxy]phenoxy}-1,4-benzodioxin-5-ol
Potential treatment - theoretical effect Experimental Antiviral Apr/25/2021
(E)-4-(4-((5-(4,5-Dimethyl-2-nitrophenyl)furan-2-yl)Methylene)-3-Methyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl)benzoic acid
Potential treatment - theoretical effect Experimental Other treatment Apr/12/2021
S-[2-[[(2R,3S,4R,5R)-3,4-Dihydroxy-5-(2-oxo-7H-pyrrolo[2,3-d]pyrimidin-3-yl)oxolan-2-yl]methoxy-[2-(2,2-dimethylpropanoylsulfanyl)ethoxy]phosphoryl]oxyethyl] 2,2-dimethylpropanethioate
Potential treatment - theoretical effect Experimental Antiviral Feb/01/2021